A thyroid condition may cause symptoms like foggy-headedness, fatigue, difficulty regulating body temperature, and slow metabolism
Should Phase 3 trials demonstrate a favourable benefit-risk profile, Eli Lilly would be expected to submit a Marketing Authorisation Application (MAA) to the MHRA (and separately to the EMA for European markets) for regulatory review
We are dedicated to fostering holistic progress that takes into account both physical and mental health
[DOI] [PubMed] [PMC] Wang P, Shen X, Wang Y, Jia X
the cortisol / HPA-axis story and why established burnout is dysregulation rather than simply high cortisol
Common sites for this type of injection include the abdomen (around the belly button area) and thighs (front or outer parts)